Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues
Oxford BioMedica (OXBDF) had Profit Margin of -33.53% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$139.37M |
|
$-46.74M |
|
$82.00M |
|
$57.37M |
|
$181.98M |
|
$-42.61M |
|
$-8.54M |
|
$-51.15M |
|
$-51.15M |
|
$-52.60M |
|
$-52.60M |
|
$-52.60M |
|
$-52.60M |
|
$-42.61M |
|
$-18.34M |
|
103.46M |
|
103.46M |
|
$-0.45 |
|
$-0.45 |
|
| Balance Sheet Financials | |
$144.13M |
|
$69.57M |
|
$106.53M |
|
$250.66M |
|
$63.11M |
|
$112.91M |
|
$122.10M |
|
$185.21M |
|
$65.45M |
|
$33.84M |
|
$65.45M |
|
105.96M |
|
| Cash Flow Statement Financials | |
$-54.83M |
|
$6.09M |
|
$3.15M |
|
$112.23M |
|
$65.63M |
|
$-46.60M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.28 |
|
-- |
|
-- |
|
0.63 |
|
1.80 |
|
41.17% |
|
-30.57% |
|
-30.57% |
|
-13.16% |
|
-36.70% |
|
|
Profit Margin |
-33.53% |
$-62.94M |
|
-- |
|
-- |
|
-- |
|
0.56 |
|
5.58 |
|
2.18 |
|
167.12 |
|
-80.36% |
|
-155.46% |
|
-20.98% |
|
-29.49% |
|
$0.62 |
|
$-0.61 |
|
$-0.53 |
|